Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
Active, not recruiting · NCT06812988 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-03-13 | NCT06812988 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advanced Research Institute - Odgen- Site Number : 8400007 | Ogden | United States | 1 |
| Atlanta Diabetes Associates- Site Number : 8400006 | Atlanta | United States | 1 |
| Centro de Diabetes Curitiba- Site Number : 0760005 | Curitiba | Brazil | 1 |
| Centro de Pesquisas Clínicas - São Paulo- Site Number : 0760002 | São Paulo | Brazil | 1 |
| IACT Health - Columbus - Talbotton Road- Site Number : 8400012 | Columbus | United States | 1 |
| Profound Research - MHP - TriAtria- Site Number : 8400015 | Farmington Hills | United States | 1 |
| Tekton Research - McKinney- Site Number : 8400017 | McKinney | United States | 1 |